Leerink Partners Analyst Initiates Coverage on Labcorp with Outperform Rating and 260 Price Target
On February 26, 2024, Michael Cherny, an analyst at Leerink Partners, began covering Laboratory Corp (NYSE:LH) with an optimistic outlook, ...
Tag: LH
Revolutionizing Decentralized Clinical Trials Labcorp and Hawthorne Effect Join Forces to Enhance Patient Experience and Accessibility
On January 10, 2024, Labcorp and Hawthorne Effect joined forces to revolutionize decentralized clinical trials, with the ultimate goal of ...
Don't Miss It
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies
